(Q35793421)

10 August 2017

title

p53 mutations and expression in breast carcinoma in situ (English)

1 reference

10 August 2017

1 reference

J Lukas

1

1 reference

10 August 2017

N Niu

series ordinal

2

1 reference

10 August 2017

M F Press

series ordinal

3

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 January 2000

1 reference

The American Journal of Pathology

10 August 2017

published in

1 reference

10 August 2017

volume

156

1 reference

10 August 2017

issue

1

1 reference

10 August 2017

page(s)

183-191

1 reference

Benign breast changes and the risk for subsequent breast cancer: an update of the 1985 consensus statement. Cancer Committee of the College of American Pathologists.

10 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1868634

Mutation of the TP53 gene and allelic imbalance at chromosome 17p13 in ductal carcinoma in situ

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1868634

Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1868634

p21WAF1 immunohistochemical expression in breast carcinoma: correlations with clinicopathological data, oestrogen receptor status, MIB1 expression, p53 gene and protein alterations and relapse-free survival

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1868634

Clinical implications of the p53 tumor-suppressor gene

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1868634

How loops, beta sheets, and alpha helices help us to understand p53.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1868634

p53 mutations are confined to the comedo type ductal carcinoma in situ of the breast. Immunohistochemical and sequencing data

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1868634

High-resolution structure of the oligomerization domain of p53 by multidimensional NMR

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1868634

Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1868634

Biomarkers in early breast neoplasia

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1868634

Immunohistochemical expression of the mutant p53 protein and nuclear DNA content during the transition from benign to malignant breast disease

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1868634

Detection and characterization of a 3' untranslated region ribonucleoprotein complex associated with human alpha-globin mRNA stability

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1868634

Immunohistochemical studies of early breast cancer evolution

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1868634

Refined solution structure of the oligomerization domain of the tumour suppressor p53

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1868634

HER-2/neu oncogene expression and DNA ploidy analysis in breast cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1868634

p53 protein expression in human breast carcinoma: relationship to expression of epidermal growth factor receptor, c-erbB-2 protein overexpression, and oestrogen receptor

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1868634

Accumulation of p53 Tumor Suppressor Gene Protein: An Independent Marker of Prognosis in Breast Cancers

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1868634

p53 mutations and expression in ovarian cancers: correlation with overall survival

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1868634

Pattern of gene alterations in intraductal breast neoplasms associated with histological type and grade.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1868634

Role of a p53 polymorphism in the development of human papillomavirus-associated cancer

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1868634

WAF1/Cip1 gene polymorphism and expression in carcinomas of the breast, ovary, and endometrium

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1868634

p53 mutations and c-erbB-2 amplification in intraductal and invasive breast carcinomas of high histologic grade.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1868634

Frequent p53 gene mutations and novel alleles in familial breast cancer.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1868634

Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1868634

Identification of two KH domain proteins in the alpha-globin mRNP stability complex

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1868634

Ductal carcinoma in situ: assessment of necrosis and nuclear morphology and their association with biological markers

25 September 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964718-9

p53 protein expression in ductal carcinoma in situ (DCIS) of the breast

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964718-9

bcl-2 expression in the spectrum of preinvasive breast lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964718-9

Ductal carcinoma in situ of the breast. Histologic categorization and its relationship to ploidy and immunohistochemical expression of hormone receptors, p53, and c-erbB-2 protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964718-9

Immunohistochemical evaluation of multiple biological markers in ductal carcinoma in situ of the breast

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964718-9

p53 protein expression in mammary ductal carcinoma in situ: Relationship to immunohistochemical expression of estrogen receptor and c-erbB-2 protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964718-9

Expression of p53 protein in infiltrating and in-situ breast carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964718-9

TP53 alterations in atypical ductal hyperplasia and ductal carcinoma in situ of the breast

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964718-9

No evidence of p53 allele-specific predisposition in human papillomavirus-associated cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964718-9

Cytoplasmic regulation of mRNA function: the importance of the 3' untranslated region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964718-9

Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964718-9

Polymorphism at codon 213 within the p53 gene

7 January 2021

1 reference

12 December 2020

p53 mutations in mammary ductal carcinoma in situ but not in epithelial hyperplasias

1 reference

12 December 2020

Maintenance of p53 alterations throughout breast cancer progression

1 reference

12 December 2020

Mammographically-detected ductal in situ carcinoma of the breast analyzed with a new classification. A study of 127 cases: correlation with estrogen and progesterone receptors, p53 and c-erbB-2 proteins, and proliferative activity

1 reference

12 December 2020

10.1016/S0002-9440(10)64718-9

Identifiers

DOI

1 reference

10 August 2017

1 reference

10 August 2017

1 reference